Herb-drug interactions with anticancer agents. A surveillance programme by the clinical pharmacist.
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Poster
- By: VIQUEZ-JAIKEL, Alvaro (Caja Costarricense de Seguro Social, Pharmacy, San Jose, Costa Rica)
- Co-author(s): Alvaro Viquez-Jaikel:
Cristina Fernandez: Pharmacy, Caja Costarricense de Seguro Social, San Jose, Costa Rica
Allan Ramos-Esquivel: Medical Oncology, Caja Costarricense de Seguro Social, San Jose, Costa Rica
Cancer patients frequently use herbal supplements in combination with antineoplastic agents. Although the majority of patients believe that these combinations do not change the efficacy or safety of their therapy there are some concerns about the clinical significance of herb-drug interactions (HDIs) that are usually disregarded by the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.